 MALVERN, Pa., July 28, 2022 GLOBE NEWSWIRE -- Neuronetics, Inc. NASDAQ: STIM, a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022. The Company is scheduled to present at 11:30 am Eastern Time the same day via webcast. 